Skip to content
Advertisement

Tom Howell Jr.

Tom Howell Jr.

Tom Howell Jr. covers politics and the White House for The Washington Times. He can be reached at thowell@washingtontimes.com.

Articles by Tom Howell Jr.

Menthol cigarettes and other tobacco products are displayed at a store in San Francisco on May 17, 2018. The U.S. government is set to release its long-awaited plan to ban menthol cigarettes and flavored cigars. On Thursday, April 28, 2022, Food and Drug Administration Commissioner Robert Califf previewed the announcement in congressional testimony, saying the proposal would reduce disease and death among smokers and help many quit. (AP Photo/Jeff Chiu, File)

FDA writes rules to prohibit menthol cigs

The Food and Drug Administration on Thursday issued rules that will prohibit menthol-flavored cigarettes and any flavor other than tobacco in cigars. Published April 28, 2022

A health worker administers a dose of a Moderna COVID-19 vaccine during a vaccination clinic in Norristown, Pa., Tuesday, Dec. 7, 2021.  Moderna on Thursday, April 28, 2022,  asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.(AP Photo/Matt Rourke, File)

Moderna asks FDA to authorize COVID-19 vaccine for under 6

Moderna asked the Food and Drug Administration to authorize its COVID-19 vaccine for children age 5 and younger, intensifying the race to immunize the 19 million Americans who remain ineligible for shots against the disease. Published April 28, 2022

A poster photo of U.S. Marine Corps veteran and Russian prisoner Trevor Reed stands in Lafayette Park near the White House, March 30, 2022, in Washington. (AP Photo/Patrick Semansky, File)

Ex-Marine Trevor Reed released from Russian custody

President Biden said Wednesday that Trevor Reed, a former Marine, has been released from Russian custody and is being returned to his family as part of a prisoner exchange. Published April 27, 2022

This image provided by Pfizer shows the company's COVID-19 Paxlovid pills. Pfizer's and Merck's COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. (Pfizer via AP, File)

WH expands access to COVID-19 pill, warns options will wane if Congress blocks virus money

White House COVID-19 Coordinator Ashish Jha said Tuesday the administration will make an all-out push to save lives with Pfizer's effective treatment for COVID-19 by nearly doubling the number of pharmacies that stock the pills and setting up federally supported "test-to-treat" sites offering the drug to people who test positive. Published April 26, 2022